- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06564688
To Explore the Functional Connectivity Pattern of Cortical Swallowing Network in the Oral Phase of Post-stroke Dysphagia Based on Dynamic Causal Modelling
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Qingqing Zhang
- Phone Number: 18150019719
- Email: 2017013@fjtcm.edu.cn
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Inclusion criteria of patients with post-stroke oral dysphagia:
- Patients with dysphagia after first stroke, meeting the diagnostic criteria of stroke, and confirmed by brain CT or brain MRI;
- Oral dysphagia caused by stroke;
- FOIS level ≤ 5; WST level ≥3;
- Those who can understand and carry out the simple instructions of the treatment staff and are willing to accept the examination and treatment;
- Clear consciousness and stable vital signs;
- Patients in the recovery stage with stroke course and dysphagia duration between 0 and 6 months;
- Right-handed;
- Voluntary participants with informed consent.
Inclusion criteria of patients without dysphagia after stroke:
- Patients with first-ever stroke, meeting the diagnostic criteria of stroke, and confirmed by brain CT or brain MRI;
- No dysphagia, FOIS level =7; WST level =1;
- Those who can understand and carry out the simple instructions of the treatment staff and are willing to accept the examination and treatment;
- Clear consciousness and stable vital signs;
- Patients in the recovery stage with stroke duration between 0 and 6 months;
- Right-handed;
- Voluntary participants with informed consent.
Inclusion criteria of healthy control group:
- Normal cognitive function and swallowing function, FOIS level =7; WST level =1;
- Gender and age matched with patients with dysphagia in the oral phase after stroke;
- Right-handed;
- Voluntary participants with informed consent.
Exclusion Criteria:
- Dysphagia not caused by stroke or non-oral dysphagia;
- History of cerebral trauma, stroke, brain tumor, cerebrovascular, intracranial infection, Parkinson's disease, epilepsy, or other neurological or psychiatric diseases;
- Symptoms of severe aphasia, neglect, visual field defect and other cortical lesions; Patients with severe cognitive impairment or depression;
- Taking or within 2 weeks of taking drugs that affect the nervous system or psychoses;
- Patients with metal implants and/or spatial claustrophobia who are not suitable for MRI scanning;
- Visual/hearing disorders affecting training and assessment;
- Persons who are participating in other research trials that may influence the results of this study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Dysphagia in the oral phase after stroke
The swallowing function was assessed by swallowing related scale and the Videofluoroscopic Swallowing Study, and then functional magnetic resonance imaging was performed.
|
The oral function score assesses the oral functional performance of chewing in all participants. The Functional oral feeding Scale (FOIS) was used to assess the ability of all participants to eat. The standardized swallowing assessment (SSA) was used to assess the global swallowing function of all participants. |
|
Without dysphagia after stroke
First, the swallowing function related scale was evaluated, and then the functional magnetic resonance imaging (fMRI) scan was performed.
|
The oral function score assesses the oral functional performance of chewing in all participants. The Functional oral feeding Scale (FOIS) was used to assess the ability of all participants to eat. The standardized swallowing assessment (SSA) was used to assess the global swallowing function of all participants. |
|
Healthy controls
First, the swallowing function related scale was evaluated, and then the functional magnetic resonance imaging (fMRI) scan was performed.
|
The oral function score assesses the oral functional performance of chewing in all participants. The Functional oral feeding Scale (FOIS) was used to assess the ability of all participants to eat. The standardized swallowing assessment (SSA) was used to assess the global swallowing function of all participants. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standard Swallowing Assessment (SSA)
Time Frame: Before fMRI scan
|
The scale has a minimum score of 18 and a maximum score of 46, with higher scores indicating poorer swallowing function
|
Before fMRI scan
|
|
Oral Functional Scale
Time Frame: Baseline
|
The Oral Functional Scale is a tool used to assess the oral functional status of an individual, with higher scores indicating better oral function
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Oral Intake Scale (FOIS)
Time Frame: Baseline
|
The Functional Oral Intake Scale (FOIS) is a reliable and valid tool for assessing functional oral food and fluid intake in patients with oropharyngeal dysphagia (OD).
Fois has seven levels, with higher levels indicating better swallowing function.
|
Baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Videofluoroscopicdysphagia scale(VDS)
Time Frame: Baseline
|
The VDS scale should be evaluated by videofluoroscopic swallowing study.
The VDS has a total of 14 items, including 2 dimensions (oral phase and phase).
Scores range from 0 to 100, with higher scores indicating greater severity of dysphagia.
|
Baseline
|
|
Water Swallowing Test (WST)
Time Frame: Baseline
|
Water Swallow Test (WST) is a method to evaluate the swallowing function of patients by observing their swallowing movements and performance during drinking water.
|
Baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023KY-015-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.